The Blame Game: Senators Target Patent Abuse as Culprit for Sky-High Drug Prices
In the ongoing saga of America’s exorbitant drug prices, a new villain has emerged on Capitol Hill: the patent system. Democrats and Republicans alike have taken aim at pharmaceutical companies, accusing them of exploiting patent laws to stifle competition and maintain their stranglehold on pricing. This bipartisan consensus underscores the urgent need for reform in […]